Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | C162F |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | VHL C162F lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). C162F leads to a loss of Vhl function as indicated by failure to bind to Elongin BC complex and inhibition of ubiquitin-dependent proteolysis in cell culture (PMID: 9447969, PMID: 11331612). |
Associated Drug Resistance | |
Category Variants Paths |
VHL mutant VHL inact mut VHL C162F |
Transcript | NM_000551.4 |
gDNA | chr3:g.10149808G>T |
cDNA | c.485G>T |
Protein | p.C162F |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000551.3 | chr3:g.10149808G>T | c.485G>T | p.C162F | RefSeq | GRCh38/hg38 |
NM_000551 | chr3:g.10149808G>T | c.485G>T | p.C162F | RefSeq | GRCh38/hg38 |
NM_000551.4 | chr3:g.10149808G>T | c.485G>T | p.C162F | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|